CA Stock MarketDetailed Quotes

INNO InnoCan Pharma Corp

Watchlist
  • 0.215
  • 0.0000.00%
15min DelayTrading Dec 5 09:30 ET
61.69MMarket Cap-17916P/E (TTM)

InnoCan Pharma Corp Key Stats

EPS
According to the latest financial report of InnoCan Pharma Corp, the latest earnings per share (TTM) for the company is -0.00. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

FCF
Interested in knowing about InnoCan Pharma Corp's free cash flow? The latest report shows it as -1.01M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of InnoCan Pharma Corp shows that the company's current ratio is 3.57, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of InnoCan Pharma Corp, the quick ratio is 2.17, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

ROE
Want to learn more about the financial health of InnoCan Pharma Corp? The latest ROE figure is -5.81%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of InnoCan Pharma Corp, the total asset return on investment (ROA) is -3.17%.

Currency: USD

Quarterly

Loading...

Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check InnoCan Pharma Corp's latest financial report to see how their gross margin is doing - currently at 90.20%.

Currency: USD

Quarterly

Loading...

Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of InnoCan Pharma Corp, the net profit margin is 3.29%, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.